-       Report 
- August 2025
-  199 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  184 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  187 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- August 2025
-  356 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
           -       Report 
- September 2025
-  100 Pages 
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
            -       Report 
- April 2025
-  139 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- October 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  193 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  182 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  156 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  400 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- July 2025
-  150 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
       
      The Gamma Camera is a type of medical imaging device used to detect and measure gamma radiation emitted from a patient's body. It is used to diagnose and monitor a variety of diseases, including cancer, heart disease, and neurological disorders. Gamma Cameras are typically used in conjunction with other imaging modalities, such as X-ray, CT, and MRI, to provide a more comprehensive view of the patient's condition. Gamma Cameras are also used in nuclear medicine, where they are used to detect and    measure radioactive substances in the body.
The Gamma Camera market is a highly competitive and rapidly evolving field. Companies in the market are focused on developing innovative technologies to improve the accuracy and efficiency of medical imaging. They are also investing in research and development to create new applications for Gamma Cameras, such as in the diagnosis and treatment of cancer.
Some of the major companies in the Gamma Camera market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, and Shimadzu Corporation. Show Less   Read more